Oncolytics Biotech logo

Oncolytics Biotech share price today

(ONCY)

Oncolytics Biotech share price is $0.93 & ₹79.80 as on 7 Jan 2025, 2.30 'hrs' IST

$0.93

-0.03

(-3.09%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Oncolytics Biotech share price in Dollar and Rupees. Guide to invest in Oncolytics Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oncolytics Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Oncolytics Biotech share price movements

  • Today's Low: $0.93
    Today's High: $0.97

    Day's Volatility :5.1%

  • 52 Weeks Low: $0.71
    52 Weeks High: $1.53

    52 Weeks Volatility :53.59%

Oncolytics Biotech Returns

PeriodOncolytics Biotech IncIndex (Russel 2000)
3 Months
-24.42%
0.0%
6 Months
-6.81%
0.0%
1 Year
-29.42%
0.0%
3 Years
-27.83%
-19.8%

Oncolytics Biotech Key Statistics

in dollars & INR

Previous Close
$0.9599
Open
$0.9677
Today's High
$0.974899
Today's Low
$0.9252
Market Capitalization
$71.4M
Today's Volume
$263.6K
52 Week High
$1.53
52 Week Low
$0.7101
Revenue TTM
$0.0
EBITDA
$-36.4M
Earnings Per Share (EPS)
$-0.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-138.22%

How to invest in Oncolytics Biotech from India?

It is very easy for Indian residents to invest directly in Oncolytics Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncolytics Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncolytics Biotech or ONCY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncolytics Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncolytics Biotech shares which would translate to 0.923 fractional shares of Oncolytics Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oncolytics Biotech, in just a few clicks!

Returns in Oncolytics Biotech for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oncolytics Biotech investment value today

Current value as on today

₹71,605

Returns

₹28,395

(-28.4%)

Returns from Oncolytics Biotech Stock

₹31,618 (-31.62%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Oncolytics Biotech

-34%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Oncolytics Biotech on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -34% less investors are searching Oncolytics Biotech in the last 30 days versus the previous period.

Global Institutional Holdings in Oncolytics Biotech

  • SEEDS INVESTOR LLC

    0.25%

  • International Assets Investment Management, LLC

    0.23%

  • Goldman Sachs Group Inc

    0.11%

  • Citadel Advisors Llc

    0.10%

  • Royal Bank of Canada

    0.10%

  • Commonwealth Equity Services Inc

    0.08%

Analyst Recommendation on Oncolytics Biotech

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Oncolytics Biotech(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Oncolytics Biotech

What analysts predicted

Upside of 421.51%

Current:

$0.93

Target:

$4.85

Insights on Oncolytics Biotech

  • Price Movement

    In the last 1 month, ONCY stock has moved up by 8.7%
  • ONCY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 47.5%
  • ONCY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 81.9%

Oncolytics Biotech Technicals Summary

Sell

Neutral

Buy

Oncolytics Biotech is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Oncolytics Biotech Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oncolytics Biotech Inc
9.08%
-6.81%
-29.42%
-27.83%
-76.0%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oncolytics Biotech Inc
NA
NA
NA
-0.45
-1.38
-0.71
NA
0.37
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oncolytics Biotech Inc
Buy
$71.4M
-76.0%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Oncolytics Biotech

oncolytics biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. the company is conducting clinical studies using reolysin®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers. oncolytics’ clinical program includes a number of human trials at a variety of stages including a phase iii trial in head and neck cancers. the company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.
Organization
Oncolytics Biotech
Employees
0
CEO
Mr. Wayne F. Pisano M.B.A.
Industry
Health Technology

Management People of Oncolytics Biotech

NameTitle
Mr. Wayne F. Pisano M.B.A.
Interim CEO & Chairman of the Board
Mr. Kirk J. Look C.A., CA
Chief Financial Officer
Dr. Matthew C. Coffey M.B.A., Ph.D.
President, CEO & Director (Leave of Absence)
Dr. Thomas C. Heineman M.D., Ph.D.
Chief Medical Officer
Ms. Allison Hagerman P.Eng., P.M.P.
Vice President of Product Development
Ms. Amy Goodowitz Levin B.S.N., R.N.
Vice President of Clinical Operations
Jon Patton
Director of Investor Relations & Communication
Mr. John Mark Lievonen B.B.A., F.C.A., FCPA, LLD, M.B.A.
Consultant

Important FAQs about investing in Oncolytics Biotech from India :

What is Oncolytics Biotech share price today?

Oncolytics Biotech share price today stands at $0.93, Open: $0.97 ; Previous Close: $0.96 ; High: $0.97 ; Low: $0.93 ; 52 Week High: $1.53 ; 52 Week Low: $0.71. The stock opens at $0.97, after a previous close of $0.96. The stock reached a daily high of $0.97 and a low of $0.93, with a 52-week high of $1.53 and a 52-week low of $0.71.

Can Indians buy Oncolytics Biotech shares?

Yes, Indians can invest in the Oncolytics Biotech (ONCY) from India.

With INDmoney, you can buy Oncolytics Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oncolytics Biotech at zero transaction cost.

How can I buy Oncolytics Biotech shares from India?

It is very easy to buy Oncolytics Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncolytics Biotech be purchased?

Yes, you can buy fractional shares of Oncolytics Biotech with INDmoney app.

What are the documents required to start investing in Oncolytics Biotech stocks?

To start investing in Oncolytics Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Oncolytics Biotech

Today’s highest price of Oncolytics Biotech (ONCY) is $0.97.

Today’s lowest price of Oncolytics Biotech (ONCY) is $0.93.

What is today's market capitalisation of Oncolytics Biotech

Today's market capitalisation of Oncolytics Biotech ONCY is 71.4M

What is the 52 Week High and Low Range of Oncolytics Biotech

  • 52 Week High

    $1.53

  • 52 Week Low

    $0.71

What are the historical returns of Oncolytics Biotech?

  • 1 Month Returns

    9.08%

  • 3 Months Returns

    -6.81%

  • 1 Year Returns

    -29.42%

  • 5 Years Returns

    -76%

Who is the Chief Executive Officer (CEO) of Oncolytics Biotech

Mr. Wayne F. Pisano M.B.A. is the current Chief Executive Officer (CEO) of Oncolytics Biotech.